Valuation: IDEXX Laboratories, Inc.

Market Cap 55.67B 49.69B 45.73B 41.5B 78.65B 5,219B 80.61B 547B 218B 2,794B 209B 204B 8,799B P/E 2026 *
47x
P/E 2027 * 42x
Enterprise Value 56.07B 50.05B 46.05B 41.8B 79.21B 5,256B 81.18B 551B 220B 2,814B 210B 206B 8,862B EV / Sales 2026 *
11.8x
EV / Sales 2027 * 10.7x
Free-Float
72.24%
Yield 2026 *
-
Yield 2027 * -
1 day+4.53%
1 week+5.21%
Current month+28.20%
1 month+36.42%
3 months+20.45%
6 months+26.16%
Current year+4.45%
1 week 650
Extreme 650
713.74
1 month 514.72
Extreme 514.725
713.74
Current year 500.61
Extreme 500.61
726.41
1 year 500.61
Extreme 500.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 107.59
Extreme 107.59
769.98
Manager TitleAgeSince
Chief Executive Officer 52 12/05/2026
Director of Finance/CFO 43 01/03/2025
Chief Operating Officer 58 01/01/2025
Director TitleAgeSince
Chairman 65 12/05/2026
Director/Board Member 64 15/07/2013
Director/Board Member 73 11/03/2014
Date Insider Type Main position Quantity % Market Cap. Importance
04/11/26 Sell

Director

-1,200 0.0015%
04/11/26 Exercice

Chairman

75,420 0.0957%
04/11/26 Sell

Executive/Senior Manager

-3,979 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
+4.53%+5.21%-0.25%+68.75% 55.67B
+0.53%+0.32%-12.54%+18.13% 191B
+0.97%+3.53%+11.49%+46.65% 126B
-0.04%+6.17%-8.51%+20.27% 124B
-1.65%+1.98%-38.20%+8.64% 98.14B
+3.66%+2.34%-4.14%+75.67% 65.98B
+1.59%+8.38%+21.04%-7.32% 58.63B
+1.42%-3.67%-5.92%+53.63% 48.78B
-0.13%+1.32%+3.73%-7.69% 36.03B
+2.70%+21.05% - - 35.77B
Average +1.36%+3.66%-3.70%+30.75% 84B
Weighted average by Cap. +0.96%+2.95%-6.18%+29.13%

Financials

2026 *2027 *
Net sales 4.75B 4.24B 3.9B 3.54B 6.71B 445B 6.88B 46.7B 18.61B 238B 17.84B 17.46B 751B 5.17B 4.62B 4.25B 3.86B 7.31B 485B 7.49B 50.84B 20.26B 260B 19.42B 19B 818B
Net income 1.19B 1.07B 981M 891M 1.69B 112B 1.73B 11.74B 4.68B 59.95B 4.48B 4.39B 189B 1.32B 1.18B 1.09B 985M 1.87B 124B 1.91B 12.99B 5.18B 66.33B 4.96B 4.86B 209B
Net Debt 395M 353M 325M 295M 559M 37.07B 573M 3.89B 1.55B 19.84B 1.48B 1.45B 62.5B -144M -129M -118M -107M -203M -13.5B -208M -1.41B -564M -7.23B -540M -529M -22.76B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
09/11/26 $706.65 +4.53% 703,732
06/11/26 $676.04 +0.79% 589,072
05/11/26 $670.71 -3.99% 873,282
04/11/26 $698.55 +3.94% 1,398,901
03/11/26 $672.04 +0.06% 1,188,052
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
706.65USD
Average target price
717.17USD
Spread / Average Target
+1.49%
  1. Stock Market
  2. Stocks
  3. IDXX Stock